triazolam has been researched along with Interstitial Nephritis in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makino, H | 1 |
| Haramoto, T | 1 |
| Sasaki, T | 1 |
| Hironaka, K | 1 |
| Shikata, K | 1 |
| Takahashi, K | 1 |
| Ota, Z | 1 |
1 other study available for triazolam and Interstitial Nephritis
| Article | Year |
|---|---|
Massive eosinophilic infiltration in a patient with the nephrotic syndrome and drug-induced interstitial nephritis.
Topics: Eosinophilia; Eosinophils; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Glomerulus; M | 1995 |